{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:55:51Z","timestamp":1776873351537,"version":"3.51.2"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.clim.2014.04.009","type":"journal-article","created":{"date-parts":[[2014,4,27]],"date-time":"2014-04-27T09:00:25Z","timestamp":1398589225000},"page":"136-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Inhibition of very late antigen-4 and leukocyte function-associated antigen-1 in experimental autoimmune uveoretinitis"],"prefix":"10.1016","volume":"153","author":[{"given":"Waka","family":"Ishida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4321-5592","authenticated-orcid":false,"given":"Yosuke","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Yagita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuki","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2014.04.009_bb0005","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00163549","article-title":"The natural history of uveitis","volume":"14","author":"Nussenblatt","year":"1990","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.clim.2014.04.009_bb0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0039-6257(01)00275-2","article-title":"Immunopathology of the noninfectious posterior and intermediate uveitides","volume":"46","author":"Boyd","year":"2001","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.clim.2014.04.009_bb0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/2013.jamaophthalmol.102","article-title":"Normative comparison of patient-reported outcomes in patients with noninfectious uveitis","volume":"131","author":"Naik","year":"2013","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.clim.2014.04.009_bb0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4049\/jimmunol.101.1.151","article-title":"Experimental allergic uveitis. I. Production in the guinea pig and rabbit by immunization with retina in adjuvant","volume":"101","author":"Wacker","year":"1968","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2014.04.009_bb0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000233339","article-title":"Cyclosporin A: alterations of the cellular immune response in S-antigen-induced experimental autoimmune uveitis","volume":"70","author":"Nussenblatt","year":"1983","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.clim.2014.04.009_bb0030","first-page":"1","article-title":"Adoptive transfer of experimental autoimmune uveoretinitis in rats. Immunopathogenic mechanisms and histologic features","volume":"26","author":"Mochizuki","year":"1985","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.clim.2014.04.009_bb0035","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.4049\/jimmunol.157.6.2668","article-title":"Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response","volume":"157","author":"Caspi","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2014.04.009_bb0040","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nm1585","article-title":"TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1","volume":"13","author":"Amadi-Obi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2014.04.009_bb0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/clin.1993.1057","article-title":"Monoclonal antibodies against ICAM-1 (CD54) and LFA-1 (CD11a\/CD18) inhibit experimental autoimmune uveitis","volume":"67","author":"Whitcup","year":"1993","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.clim.2014.04.009_bb0050","first-page":"2626","article-title":"Suppression of experimental uveitis with monoclonal antibodies to ICAM-1 and LFA-1","volume":"35","author":"Uchio","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.clim.2014.04.009_bb0055","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1167\/iovs.06-1383","article-title":"Suppression of established experimental autoimmune uveitis by anti-LFA-1alpha Ab","volume":"48","author":"Ke","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.clim.2014.04.009_bb0060","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1167\/iovs.04-0418","article-title":"Administration of a peptide inhibitor of alpha4-integrin inhibits the development of experimental autoimmune uveitis","volume":"46","author":"Martin","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.clim.2014.04.009_bb0065","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa020732","article-title":"Natalizumab for active Crohn's disease","volume":"348","author":"Ghosh","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2014.04.009_bb0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJMoa020696","article-title":"A controlled trial of natalizumab for relapsing multiple sclerosis","volume":"348","author":"Miller","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2014.04.009_bb0075","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1470-2045(09)70161-5","article-title":"Monoclonal antibody-associated progressive multifocal leukoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the Research on Adverse Drug Events and Reports (RADAR) Project","volume":"10","author":"Carson","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.clim.2014.04.009_bb0080","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3109\/09273948.2010.483317","article-title":"Intercellular adhesion molecule inhibitors as potential therapy for refractory uveitic macular edema","volume":"18","author":"Wang","year":"2010","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.clim.2014.04.009_bb0085","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1167\/iovs.10-5896","article-title":"Treatment of inflammatory macular edema with humanized anti-CD11a antibody therapy","volume":"52","author":"Faia","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.clim.2014.04.009_bb0090","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1167\/iovs.10-6115","article-title":"Dynamic changes of microRNAs in the eye during the development of experimental autoimmune uveoretinitis","volume":"52","author":"Ishida","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.clim.2014.04.009_bb0095","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1084\/jem.20071258","article-title":"Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category","volume":"205","author":"Luger","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2014.04.009_bb0100","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1084\/jem.20110434","article-title":"Th17 lymphocytes traffic to the central nervous system independently of alpha4 integrin expression during EAE","volume":"208","author":"Rothhammer","year":"2011","journal-title":"J. Exp. Med."},{"issue":"Unit 15 6","key":"10.1016\/j.clim.2014.04.009_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1506s53","article-title":"Experimental autoimmune uveoretinitis in the rat and mouse","volume":"Chapter 15","author":"Caspi","year":"2003","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.clim.2014.04.009_bb0110","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.4049\/jimmunol.153.12.5810","article-title":"Immunosuppression to cardiac allografts and soluble antigens by anti-vascular cellular adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies","volume":"153","author":"Isobe","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2014.04.009_bb0115","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2249.1995.tb03790.x","article-title":"Prevention of adoptive transfer of murine Sjogren's syndrome into severe combined immunodeficient (SCID) mice by antibodies against intercellular adhesion molecule-1 (ICAM-1) and lymphocyte function-associated antigen-1 (LFA-1)","volume":"102","author":"Hayashi","year":"1995","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2014.04.009_bb0120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/BF02918368","article-title":"Accessory cell-derived signals required for T cell activation","volume":"12","author":"Johnson","year":"1993","journal-title":"Immunol. Res."},{"key":"10.1016\/j.clim.2014.04.009_bb0125","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1016\/j.jaad.2005.10.029","article-title":"Relapse, rebound, and psoriasis adverse events: an advisory group report","volume":"54","author":"Carey","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.clim.2014.04.009_bb0130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaad.2007.08.030","article-title":"From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis","volume":"58","author":"Lebwohl","year":"2008","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661614001168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661614001168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T12:14:22Z","timestamp":1689164062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661614001168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1521661614001168"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2014.04.009","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of very late antigen-4 and leukocyte function-associated antigen-1 in experimental autoimmune uveoretinitis","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2014.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}